CAD 0.06
(10.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.45 Million | -221.55 Thousand | -940.18 Thousand | -1.18 Million | -1.41 Million | -915.95 Thousand |
Net Income | -3.28 Million | -725.09 Thousand | -1.73 Million | -1.43 Million | -1.88 Million | -1.92 Million |
Depreciation & Amortization | 83.33 Thousand | 83.33 Thousand | - | - | - | - |
Deferred income taxes | - | -241.35 Thousand | - | - | - | - |
Stock-based compensation | 1.7 Million | 11.25 Thousand | 92.35 Thousand | 180.6 Thousand | 181.1 Thousand | 209.2 Thousand |
Change in working capital | -1.06 Million | 342.54 Thousand | 661.52 Thousand | 56.33 Thousand | 291.31 Thousand | -54.54 Thousand |
Other non-cash items | 1.91 Million | 318.99 Thousand | 36.33 Thousand | 9482.00 | 69.32 Thousand | 855.52 Thousand |
Investing Cash Flow | - | -7740.25 | - | - | -961.79 Thousand | -5.12 Million |
Investments in PPE | -2.00 | - | - | - | -961.79 Thousand | -5.04 Million |
Acquisitions | - | - | - | - | - | -79.27 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | -4.79 Million |
Financing Cash Flow | 3.01 Million | 229.3 Thousand | 976.37 Thousand | 881.32 Thousand | 1.4 Million | 2.31 Million |
Debt repayment | -250 Thousand | -200 Thousand | -175 Thousand | -295 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -30.3 Thousand | - | - | - | - |
Common Stock Issuance | 3.26 Million | 29.3 Thousand | 838.71 Thousand | 620.2 Thousand | 1.44 Million | 2.45 Million |
Other Financing Activities | -377.81 Thousand | -700.00 | 312.66 Thousand | 556.12 Thousand | -40.85 Thousand | -140.34 Thousand |
Accounts receivables | 69.51 Thousand | -74.67 Thousand | -2283.00 | 2686.00 | 109.15 Thousand | -109.15 Thousand |
Accounts payables | - | - | 670.42 Thousand | 55.96 Thousand | 166.66 Thousand | 15.19 Thousand |
Inventory | - | - | 2283.00 | -2686.00 | - | - |
Other working capital | -1.13 Million | 417.22 Thousand | -8898.00 | 370.00 | 15.49 Thousand | 39.41 Thousand |
Cash at beginning of period | 3751.00 | 56.38 Thousand | 19.18 Thousand | 315.71 Thousand | 345.25 Thousand | 4.07 Million |
Cash at end of period | 552.89 Thousand | 3751.00 | 56.38 Thousand | 19.18 Thousand | 315.71 Thousand | 345.25 Thousand |
Capital Expenditure | -2.00 | - | - | - | -961.79 Thousand | -5.04 Million |
Effect of forex changes on cash | -11.57 Thousand | -60.38 Thousand | 1015.00 | 10.76 Thousand | -15.73 Thousand | - |
Net cash flow / Change in cash | 549.14 Thousand | -52.63 Thousand | 37.2 Thousand | -296.52 Thousand | -29.54 Thousand | -3.73 Million |
Free Cash Flow | -2.45 Million | -221.55 Thousand | -940.18 Thousand | -1.18 Million | -2.37 Million | -5.96 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -474.88 Thousand | -3.28 Million | -2.41 Million | -407.84 Thousand | -285.45 Thousand | -179.36 Thousand |
Depreciation & Amortization | - | 83.33 Thousand | 83.33 Thousand | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 59.1 Thousand | 1.7 Million | 1.7 Million | - | - | - |
Change in working capital | -285.07 Thousand | -1.06 Million | 261.93 Thousand | -1.11 Million | -476.99 Thousand | 257.46 Thousand |
Other non-cash items | 3131.00 | 1.91 Million | 1.85 Million | 29.04 Thousand | 30.69 Thousand | 29.57 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | -1.00 | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 3.28 Million | 3.01 Million | 60 Thousand | 1.64 Million | 1.31 Million | - |
Debt repayment | -660.34 Thousand | -250 Thousand | - | -250 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 4.13 Million | 3.26 Million | 60 Thousand | 1.89 Million | 231.7 Thousand | - |
Other Financing Activities | -186.17 Thousand | -377.81 Thousand | 60 Thousand | 1644.28 | 1.08 Million | - |
Accounts receivables | - | 69.51 Thousand | 39.41 Thousand | -36.35 Thousand | -32.24 Thousand | 98.7 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -8181.00 | -1.13 Million | 222.52 Thousand | -1.07 Million | -444.74 Thousand | 158.76 Thousand |
Cash at beginning of period | 552.89 Thousand | 3751.00 | 837.13 Thousand | 682.56 Thousand | 126.37 Thousand | 3751.00 |
Cash at end of period | 3.14 Million | 552.89 Thousand | 552.89 Thousand | 837.13 Thousand | 682.56 Thousand | 126.37 Thousand |
Capital Expenditure | -1.00 | - | - | - | - | - |
Effect of forex changes on cash | 1280.00 | -11.57 Thousand | -3164.00 | 1014.00 | -24.37 Thousand | 14.94 Thousand |
Net cash flow / Change in cash | 2.58 Million | 549.14 Thousand | -284.24 Thousand | 154.57 Thousand | 556.18 Thousand | 122.62 Thousand |
Free Cash Flow | -697.73 Thousand | -2.45 Million | -341.08 Thousand | -1.49 Million | -731.75 Thousand | 107.67 Thousand |
NEX
MEDP
GCTS
300839
KEL
601225